Search
Pediatric oncologist Scott A. Armstrong has been named the incumbent of the Grayer Family Chair, and stem cell biologist Kitai Kim has been named to a Geoffrey Beene Junior Faculty Chair.
Campaign — inspired by Matthew Heineman’s new documentary, ‘American Symphony,’ featuring Jon Batiste and Suleika Jaouad — aims to bridge the blood stem cell and marrow donor gap and give hope to patients in need.
The SNO Lifetime Achievement Award is given annually to a meritorious individual who has made significant contributions in neuro-oncology over their career in clinical care and/or translational or basic research.
Meet Victoria “Vikki” Mills, Associate Director of Research Administration Operations at Memorial Sloan Kettering, who is deeply satisfied with her work and delighted with her family, which will soon expand — Vikki is expecting her second child in August with her fiancée, Shauna.
Scientists at Sloan Kettering Institute have discovered that the α6ß4 integrin, one of several receptor proteins, plays a key role in signaling for the formation of new blood vessels for a tumor, a process called tumor angiogenesis. By blocking the signaling activity of the α6ß4 subunit of this integrin on vascular cells, researchers found they could slow the growth of tumors.
MSK surgeon James Eastham explains the pros and cons of PSA testing and weighs in on a new US Preventive Services Task Force guideline.
Researchers have gained new understanding of how tumors metastasize by studying the behavior of exceptional breast and lung cancer cells that are capable of entering the brain and surviving there.
Learn how experts at MSK who helped develop CAR T cell therapy to fight cancer are making the treatment stronger, safer, more durable and accessible to more people.
Prostate cancer patients who are prescribed oral erectile medication before and after radiation therapy have improved sexual function, according to a research team at Memorial Sloan Kettering Cancer Center.
The pictures provide new clues about how the androgen receptor interacts with cancer-causing proteins.